These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1656857)

  • 21. Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae.
    Rocker A; Lacey JA; Belousoff MJ; Wilksch JJ; Strugnell RA; Davies MR; Lithgow T
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffusion of meropenem and imipenem through the outer membrane of Escherichia coli K-12 and correlation with their antibacterial activities.
    Cornaglia G; Guan L; Fontana R; Satta G
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1902-8. PubMed ID: 1416880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Klebsiella pneumoniae Major Porins OmpK35 and OmpK36 Allow More Efficient Diffusion of β-Lactams than Their Escherichia coli Homologs OmpF and OmpC.
    Sugawara E; Kojima S; Nikaido H
    J Bacteriol; 2016 Dec; 198(23):3200-3208. PubMed ID: 27645385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imipenem resistance in Klebsiella pneumoniae is associated to the combination of plasmid-mediated CMY-4 AmpC β-lactamase and loss of an outer membrane protein.
    Dahmen S; Mansour W; Charfi K; Boujaafar N; Arlet G; Bouallègue O
    Microb Drug Resist; 2012 Oct; 18(5):479-83. PubMed ID: 22690752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model.
    Tängdén T; Adler M; Cars O; Sandegren L; Löwdin E
    J Antimicrob Chemother; 2013 Jun; 68(6):1319-26. PubMed ID: 23478794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of resistance to beta-lactam antibiotics in Acinetobacter calcoaceticus.
    Obara M; Nakae T
    J Antimicrob Chemother; 1991 Dec; 28(6):791-800. PubMed ID: 1816177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penetration of beta-lactams through Pseudomonas aeruginosa porin channels.
    Godfrey AJ; Bryan LE
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1216-21. PubMed ID: 2443074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outer membrane permeability in Pseudomonas cepacia: diminished porin content in a beta-lactam-resistant mutant and in resistant cystic fibrosis isolates.
    Aronoff SC
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1636-9. PubMed ID: 2855296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of Escherichia coli to various beta-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic beta-lactamases: a quantitative predictive treatment.
    Nikaido H; Normark S
    Mol Microbiol; 1987 Jul; 1(1):29-36. PubMed ID: 3330755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mechanism of resistance of Pseudomonas aeruginosa to beta-lactam antibiotics and clinical significance.
    Song J; Ruan Q; Qi J; Gao M; Wang Y
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(4):339-42. PubMed ID: 12674775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Resistance to quinolones and beta-lactams in Salmonella enterica due to mutations in topoisomerase-encoding genes, altered cell permeability and expression of an active efflux system].
    Miró E; Vergés C; García I; Mirelis B; Navarro F; Coll P; Prats G; Martínez-Martínez L
    Enferm Infecc Microbiol Clin; 2004 Apr; 22(4):204-11. PubMed ID: 15056435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of Serratia marcescens porins in antibiotic resistance.
    Ruiz N; Montero T; Hernandez-Borrell J; Viñas M
    Microb Drug Resist; 2003; 9(3):257-64. PubMed ID: 12959404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of outer membrane porin alteration in beta-lactam-antibiotic-resistant Enterobacter aerogenes.
    Charrel RN; Pagès JM; De Micco P; Mallea M
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2854-8. PubMed ID: 9124854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of cross-resistance to imipenem and other beta-lactam antibiotics in Pseudomonas aeruginosa during therapy.
    Pagani L; Landini P; Luzzaro F; Debiaggi M; Romero E
    Microbiologica; 1990 Jan; 13(1):43-53. PubMed ID: 2155376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A plasmid-mediated CMY-2 beta-lactamase from an Algerian clinical isolate of Salmonella senftenberg.
    Koeck JL; Arlet G; Philippon A; Basmaciogullari S; Thien HV; Buisson Y; Cavallo JD
    FEMS Microbiol Lett; 1997 Jul; 152(2):255-60. PubMed ID: 9231418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae.
    Ubukata K; Shibasaki Y; Yamamoto K; Chiba N; Hasegawa K; Takeuchi Y; Sunakawa K; Inoue M; Konno M
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1693-9. PubMed ID: 11353613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conditional transduction of Salmonella typhimurium envB mutations.
    Antón DN
    J Bacteriol; 1987 Apr; 169(4):1767-71. PubMed ID: 3549704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of drug-resistance mechanism of Pseudomonas aeruginosa developing from a sensitive strain to a persister during carbapenem treatment.
    Shen JL; Fang YP
    Genet Mol Res; 2015 Jun; 14(2):6723-32. PubMed ID: 26125881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant.
    Angus BL; Carey AM; Caron DA; Kropinski AM; Hancock RE
    Antimicrob Agents Chemother; 1982 Feb; 21(2):299-309. PubMed ID: 6803666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.